Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 8, 2025 • 4:00 PM ET

Date/Time Source News Release
01/14/2025 08:00 AM EST GlobeNewswire Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus's Spinoff Company for Rose Bengal-Based Eye Drugs
12/11/2024 09:00 AM EST GlobeNewswire Provectus Biopharmaceuticals Launches VisiRose, Provectus's Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
10/24/2024 08:00 AM EDT GlobeNewswire Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
10/10/2024 08:00 AM EDT GlobeNewswire Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
06/13/2024 08:00 AM EDT GlobeNewswire Provectus Biopharmaceuticals Announces Investor Webinar for 2024 Annual Meeting of Stockholders
05/21/2024 08:00 AM EDT GlobeNewswire Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual Meeting
05/14/2024 08:00 AM EDT GlobeNewswire Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2024 Annual Meeting
05/02/2024 08:00 AM EDT GlobeNewswire Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of Rose Bengal Sodium in Hematology (Leukemia)
04/18/2024 08:00 AM EDT GlobeNewswire Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
04/16/2024 08:00 AM EDT GlobeNewswire Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
Page

Additional News

As of June 8, 2025 • 4:00 PM ET

Date/Time Source News Release
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:31 AM EDT US Earnings Reports Expected earnings - Provectus Biopharmaceuticals Inc
03/27/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 27th, 2025
03/27/2025 05:31 AM EDT US Earnings Reports Expected earnings - Provectus Biopharmaceuticals Inc
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Provectus Biopharmaceuticals Inc
11/14/2024 05:10 PM EST SeekingAlpha Provectus Biopharmaceuticals, Inc. (PVCT) Q4 2024 Earnings Call Transcript
11/14/2024 08:14 AM EST SeekingAlpha Provectus Biopharmaceuticals GAAP EPS of $0.00, revenue of $0.11M
11/13/2024 10:00 AM EST SeekingAlpha Here are the major earnings after the close today
04/16/2024 11:05 AM EDT SeekingAlpha Provectus appoints Pershing as CEO, Rodrigues as president
02/22/2024 06:56 PM EST SeekingAlpha Provectus Biopharmaceuticals, Inc. (PVCT) Q1 2024 Earnings Call Transcript
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.